The Cooper Companies, Inc. (COO)
| Market Cap | 19.17B |
| Revenue (ttm) | 2.43B |
| Net Income (ttm) | 238.40M |
| Shares Out | 53.34M |
| EPS (ttm) | 4.81 |
| PE Ratio | 81.52 |
| Forward PE | 31.55 |
| Dividend | $0.06 |
| Dividend Yield | 0.02% |
| Trading Day | February 25 |
| Last Price | $392.13 |
| Previous Close | $392.57 |
| Change ($) | -0.44 |
| Change (%) | -0.11% |
| Day's Open | 392.91 |
| Day's Range | 387.71 - 394.86 |
| Day's Volume | 318,034 |
| 52-Week Range | 236.63 - 396.86 |
Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.
SAN RAMON, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021. Daniel McB...
LOS ANGELES--(BUSINESS WIRE)---- $COO #COO--Angeles Equity Partners Names Annie Chau Chief Operating and Compliance Officer
SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET...
CHARENTON-LE-PONT, France, and SAN RAMON, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- EssilorLuxottica and CooperCompanies, two of the world's leading vision care companies, have entered into an...
Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Cooper Companies (COO) arm's buyout drives its growing portfolio of medical products, which revolves around clinic and practice-based women's healthcare
Employees give company culture high marks for fairness, respect, and pride Employees give company culture high marks for fairness, respect, and pride
SAN RAMON, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), announced today that consistent with the plan approved by its board of directors to pay annual dividends, the ...
Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.
SAN RAMON, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021. Al White, President and C...
SAN RAMON, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced that it will hold its next annual meeting of stockholders on Wednesday, March 17, 2021. Stockhol...
SAN RAMON, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) announced today that A. Thomas Bender and Allan E. Rubenstein, M.D. have decided to retire and will not stand fo...
Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.
The Cooper Companies, Inc. (COO) CEO Al White on Q4 2020 Results - Earnings Call Transcript
Cooper Cos. (COO) delivered earnings and revenue surprises of 1.61% and 0.38%, respectively, for the quarter ended October 2020.
Shares of Cooper Companies (NYSE:COO) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 4.24% year over year to $3.16, which be...
SAN RAMON, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2020.
Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
Cooper Companies' (COO) fiscal fourth-quarter performance is likely to reflect better performance by CVI and CSI.
Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.
SAN RAMON, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors elected Teresa S. Madden to the Board as an independent director, e...
In this article we are going to use hedge fund sentiment as a tool and determine whether The Cooper Companies, Inc. (NYSE:COO) is a good investment right now. We like to analyze hedge fund sen...
SAN RAMON, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 20...
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
After a 43% rise since the March 23 lows of this year, at the current price of around $348 per share we believe Cooper stock (NYSE: COO), best known for its Cooper Vision lenses, has reached i...
Data from NYU Langone Fertility Center Study P resented at American Society of Reproductive Medicine Annual Meeting
Cooper Cos. (COO) reported earnings 30 days ago.
Let's keep a watch on potentially strong three stocks in the dental space that have shown promise during the pandemic.
Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.
Losing sleep over Tesla's dramatic ups and downs? Consider these conservative choices, so you're not left tossing and turning all night.
CooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine CooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine
The Cooper (COO) saw a big move last session, as its shares jumped nearly 5% on the day, amid huge volumes.
Cooper Companies' (COO) fiscal third-quarter earnings reflect dismal segmental performance. However, it exceeded expectation as it witnessed faster-than-anticipated recovery.
The Cooper Companies, Inc. (COO) CEO Al White on Q3 2020 Results - Earnings Call Transcript
Cooper Cos. (COO) delivered earnings and revenue surprises of 44.30% and 7.81%, respectively, for the quarter ended July 2020.
Shares of Cooper Companies (NYSE:COO) increased 3.97% in after-market trading after the company reported Q3 results.
SAN RAMON, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, on September 23, 2020. B...
Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.
Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
SAN RAMON, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, on September 16, 20...
SAN RAMON, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the 2020 Wells Fargo Virtual Healthcare Conference, on September 10, 2020. Al White, Pre...
SAN RAMON, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release third quarter 2020 financial results on Thursday, September 3, 2020, at 4:15 ...
These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.
SAN RAMON, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), announced today that consistent with the plan approved by its board of directors to pay annual dividends, th...
SAN RAMON, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced that Holly Sheffield has been appointed President of CooperSurgical effective July 13, 2020, r...
Near-Term Outlook Bleak for Medical Dental Supplies Industry
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from.
About COO
The Cooper Companies operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, an... [Read more...]
| Industry Medical Instruments & Supplies | Founded 1980 |
| CEO Albert White | Employees 12,000 |
| Stock Exchange NYSE | Ticker Symbol COO |
Financial Performance
In 2020, COO's revenue was $2.43 billion, a decrease of -8.39% compared to the previous year's $2.65 billion. Earnings were $238.40 million, a decrease of -48.92%.
Analyst Forecasts
According to 16 analysts, the average rating for COO stock is "Buy." The 12-month stock price forecast is 382.75, which is a decrease of -2.39% from the latest price.